Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The effectiveness of the Mediterranean diet (MD) in non-alcoholic fatty liver disease (NAFLD) subjects has been evaluated in several randomized controlled trials (RCTs). This systematic review and meta-analysis aimed to evaluate the overall effects of MD intervention in a cohort of NAFLD patients targeting specific markers such as central obesity, lipid profile, liver enzymes and fibrosis, and intrahepatic fat (IHF). Google Scholar, PubMed, and Scopus were explored to collect relevant studies from the last 10 years. RCTs with NAFLD subjects were included in this systematic review with a mean intervention duration from 6 weeks to 1 year, and different intervention strategies, mainly including energy restriction MD (normal or low glycaemic index), low-fat MD with increased monounsaturated and polyunsaturated fatty acids, and increased exercise expenditure. The outcomes measured in this meta-analysis were gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), total cholesterol (TC), waist circumference (WC), and liver fibrosis. Ten randomized controlled trials, which involved a total of 737 adults with NAFLD, were included. According to the results, the MD seems to decrease the liver stiffness (kPa) by –0.42 (CI95% –0.92, 0.09) (p = 0.10) and significantly reduce the TC by –0.46 mg/dl (CI95% –0.55, −0.38) (p = 0.001), while no significant findings were documented for liver enzymes and WC among patients with NAFLD. In conclusion, the MD might reduce indirect and direct outcomes linked with NAFLD severity, such as TC, liver fibrosis, and WC, although it is important to consider the variations across trials. Further RCTs are necessary to corroborate the findings obtained and provide further evidence on the role of the MD in the modulation of other disorders related to NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effect of MD on ALT [39,40,41,44,45,46].](https://figures.cochat.ai/paper-figures/74a3df0353424b4192e19b8d2e03beb7/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-2.jpg)
![Figure 3 The effect of the MD on GGT [39,40,41,44,45].](https://figures.cochat.ai/paper-figures/d2edf81c83d94973a3aa08511a275678/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-3.jpg)
![Figure 4 The effect of the MD on liver stiffness [39,40,41,44].](https://figures.cochat.ai/paper-figures/bad38037007f4d948f588a01e100db54/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-4.jpg)
![Figure 5 The effect of the MD on TC [39,40,42,44,45,48].](https://figures.cochat.ai/paper-figures/4459a84732404d349036a779be5f4254/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-5.jpg)
![Figure 6 The effect of the MD on WC. Abbreviations: SD: standard deviation; mean: mean difference changes pre-post [39,40,41,44,45,46,48].](https://figures.cochat.ai/paper-figures/3d05db80ae234019997fb44af5bef4da/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While Del Bo et al. [15] found no significant effect of the MD on WC and the level of liver enzymes including ALT, and GGT in MASLD patients.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Estruch, R., Martínez-González, M. A., Corella, D., Salas-Salvadó, J., Fitó, M., Chiva-Blanch, G., Fiol, M., Gómez-Gracia, E., Arós, F., Lapetra, J., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30085-7 · Cited by 195
RetractedEstruch, R., Martínez-González, M. A., Corella, D., Salas-Salvadó, J., Fitó, M., Chiva-Blanch, G., Fiol, M., Gómez-Gracia, E., Arós, F., Lapetra, J., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30074-9 · Cited by 147
RetractedThe PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · cited 1×
“Apart from the direct causes of it, NAFLD can also be caused by secondary causes such as the use of steatogenic medication for lengthy periods, in addition to genetic influences [5].”
BackgroundGlobal burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 3×
“SFA may promote cellular dysfunction by activating ER stress pathways, upregulating NAFLD-associated pathways, and both systemic and hepatic insulin resistance, as well as contributing to the intrahepatic triglyceride (IHTG) pool [69,70].”
BackgroundByrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858 · cited 1×
“It is also reported to affect about 25% of the world’s population [4].”
BackgroundTHE DIET AND 15-YEAR DEATH RATE IN THE SEVEN COUNTRIES STUDY
KEYS, A., MIENOTTI, A., KARVONEN, M. J., ARAVANIS, C., BLACKBURN, H., BUZINA, R., DJORDJEVIC, B. S., DONTAS, A. S., FIDANZA, F., KEYS, M. H., et al. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114480 · Cited by 1,790 · cited 1×
“The first scientific evidence on the health benefits of the MD derives from the Seven Countries Study [15], in which Keys and colleagues documented a low incidence and mortality due to cardiovascular disease (CVD) among subjects living in the Mediterranean area compared to other countries.”
BackgroundThe Mediterranean diet and health: a comprehensive overview
Guasch‐Ferré, M., & Willett, W. C. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13333 · Cited by 940
Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778 · cited 4×
“[46] Total: 12 6 F, 6 M Australia NAFLD patients with MetS 1.”
BackgroundResultInfluentialSo, D., Whelan, K., Rossi, M., Morrison, M., Holtmann, G., Kelly, J. T., Shanahan, E. R., Staudacher, H. M., & Campbell, K. L. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy041 · Cited by 683
Trichopoulou, A., Martínez-González, M. A., Tong, T. Y., Forouhi, N. G., Khandelwal, S., Prabhakaran, D., Mozaffarian, D., & de Lorgeril, M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-112 · Cited by 656 · cited 1×
“However, MD includes a moderate intake of fish, a low-tomoderate intake of dairy products, a low intake of sweets and meat (especially red meat), and a moderate intake of alcohol (primarily in the form of wine that is consumed with meals) [12].”
BackgroundPolyunsaturated fatty acids and inflammation
Calder, P. C. (2006) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.012 · Cited by 638
Imamura, F., Micha, R., Wu, J. H. Y., de Oliveira Otto, M. C., Otite, F. O., Abioye, A. I., & Mozaffarian, D. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002087 · Cited by 479 · cited 1×
“PUFAs, omega-3 fatty acids in particular, have been reported to improve insulin sensitivity and to reduce inflammation and oxidative stress [30,31].”
BackgroundRosato, V., Temple, N. J., La Vecchia, C., Castellan, G., Tavani, A., & Guercio, V. (2019) · European Journal of Nutrition · doi:10.1007/s00394-017-1582-0 · Cited by 479
Grosso, G., Marventano, S., Yang, J., Micek, A., Pajak, A., Scalfi, L., Galvano, F., & Kales, S. N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1107021 · Cited by 456
Pathogenesis and Prevention of Hepatic Steatosis.
Nassir, F., Rector, R. S., Hammoud, G. M., & Ibdah, J. A. (2015) · PubMed · Cited by 452
Insulin Resistance in Nonalcoholic Fatty Liver Disease
Bugianesi, E., Moscatiello, S., Ciaravella, M. F., & Marchesini, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208875 · Cited by 446
Leamy, A. K., Egnatchik, R. A., & Young, J. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.10.004 · Cited by 412 · cited 1×
“SFA may promote cellular dysfunction by activating ER stress pathways, upregulating NAFLD-associated pathways, and both systemic and hepatic insulin resistance, as well as contributing to the intrahepatic triglyceride (IHTG) pool [69,70].”
BackgroundBecerra-Tomás, N., Blanco Mejía, S., Viguiliouk, E., Khan, T., Kendall, C. W. C., Kahleova, H., Rahelić, D., Sievenpiper, J. L., & Salas-Salvadó, J. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1565281 · Cited by 300
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Delli Bovi, A. P., Marciano, F., Mandato, C., Siano, M. A., Savoia, M., & Vajro, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595371 · Cited by 289
Vinelli, V., Biscotti, P., Martini, D., Del Bo’, C., Marino, M., Meroño, T., Nikoloudaki, O., Calabrese, F. M., Turroni, S., Taverniti, V., et al. (2022) · Nutrients · doi:10.3390/nu14132559 · Cited by 287
Self-citationSchwingshackl, L., & Hoffmann, G. (2015) · Cancer Medicine · doi:10.1002/cam4.539 · Cited by 275
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
SHANG, J., CHEN, L.-L., XIAO, F.-X., SUN, H., DING, H.-C., & XIAO, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00807.x · Cited by 274
Systematic Review of the Mediterranean Diet for Long-Term Weight Loss
Mancini, J. G., Filion, K. B., Atallah, R., & Eisenberg, M. J. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.11.028 · Cited by 248 · cited 2×
“The administration and following-up of the MD are beneficial as a weight loss strategy among overweight and obese people [61].”
BackgroundMoreno-Luna, R., Muñoz-Hernandez, R., Miranda, M. L., Costa, A. F., Jimenez-Jimenez, L., Vallejo-Vaz, A. J., Muriana, F. J. G., Villar, J., & Stiefel, P. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.128 · Cited by 241 · cited 1×
“Other studies documented an increase in the HDL-mediated macrophage cholesterol efflux capability, HDL antioxidant activity, and HDL anti-inflammatory features [76].”
BackgroundPaniagua, J. A., de la Sacristana, A. G., Romero, I., Vidal-Puig, A., Latre, J. M., Sanchez, E., Perez-Martinez, P., Lopez-Miranda, J., & Perez-Jimenez, F. (2007) · Diabetes Care · doi:10.2337/dc06-2220 · Cited by 237
Godos, J., Zappalà, G., Bernardini, S., Giambini, I., Bes-Rastrollo, M., & Martinez-Gonzalez, M. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1221900 · Cited by 236
The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management
Berná, G., & Romero‐Gomez, M. (2020) · Liver International · doi:10.1111/liv.14360 · Cited by 235
Properzi, C., O'Sullivan, T. A., Sherriff, J. L., Ching, H. L., Jeffrey, G. P., Buckley, R. F., Tibballs, J., MacQuillan, G. C., Garas, G., & Adams, L. A. (2018) · Hepatology · doi:10.1002/hep.30076 · Cited by 227 · cited 4×
“[44] 51 NAFLD patients were divided into two dietary intervention groups (MD or low-fat (LF) diet) for three months.”
BackgroundInfluentialKontogianni, M. D., Tileli, N., Margariti, A., Georgoulis, M., Deutsch, M., Tiniakos, D., Fragopoulou, E., Zafiropoulou, R., Manios, Y., & Papatheodoridis, G. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2013.08.014 · Cited by 221
Haigh, L., Kirk, C., El Gendy, K., Gallacher, J., Errington, L., Mathers, J. C., & Anstee, Q. M. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.06.037 · Cited by 209 · cited 1×
“[54] the authors showed that MD induced a reduction in ALT activity and liver stiffness in subjects with NAFLD.”
BackgroundMediterranean Diet as a Tool to Combat Inflammation and Chronic Diseases. An Overview
Tsigalou, C., Konstantinidis, T., Paraschaki, A., Stavropoulou, E., Voidarou, C., & Bezirtzoglou, E. (2020) · Biomedicines · doi:10.3390/biomedicines8070201 · Cited by 208
The potential of flavonoids in the treatment of non-alcoholic fatty liver disease
Van De Wier, B., Koek, G. H., Bast, A., & Haenen, G. R. M. M. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.952399 · Cited by 192
Parnell, J. A., Raman, M., Rioux, K. P., & Reimer, R. A. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02730.x · Cited by 189
Relationship between Mediterranean Dietary Polyphenol Intake and Obesity
Castro-Barquero, S., Lamuela-Raventós, R. M., Doménech, M., & Estruch, R. (2018) · Nutrients · doi:10.3390/nu10101523 · Cited by 173 · cited 1×
“MD is also characterized by the high content of numerous bioactive compounds such as carotenoids [85,86], but of PPs above all others [87,88].”
BackgroundDietary strategies implicated in the prevention and treatment of metabolic syndrome
De la Iglesia, R., Loria-Kohen, V., Zulet, M., Martinez, J., Reglero, G., & Ramirez de Molina, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111877 · Cited by 168 · cited 1×
“Several dietary approaches have been studied over the years, such as energy-restricted diets, diets rich in omega- 3 fatty acids, low glycemic index/load diets, diets with high total antioxidant capacity, moderate-high protein diets, high meal frequency patterns, and the Mediterranean diet (MD) [11].”
BackgroundPolyphenols and non-alcoholic fatty liver disease: impact and mechanisms
Rodriguez-Ramiro, I., Vauzour, D., & Minihane, A. M. (2016) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115004218 · Cited by 168
Katsagoni, C. N., Papatheodoridis, G. V., Ioannidou, P., Deutsch, M., Alexopoulou, A., Papadopoulos, N., Papageorgiou, M.-V., Fragopoulou, E., & Kontogianni, M. D. (2018) · British Journal of Nutrition · doi:10.1017/s000711451800137x · Cited by 167 · cited 6×
“Seven measured the intrahepatic fat content (IHF) [39–44,46]; six measured hepatic stiffness and steatosis [39,40,42,43,45,47]; and three measured the fatty liver index (FLI) as a score to indicate severity [43,45,47].”
BackgroundMethodInfluentialDinu, M., Pagliai, G., Angelino, D., Rosi, A., Dall'Asta, M., Bresciani, L., Ferraris, C., Guglielmetti, M., Godos, J., Del Bo', C., et al. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa006 · Cited by 164 · cited 2×
“Dinu and coworkers [20], in their umbrella review of a meta-analysis of RCT Figure 7.”
BackgroundSelf-citationn-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review
Wang, M., Ma, L.-J., Yang, Y., Xiao, Z., & Wan, J.-B. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1544542 · Cited by 158 · cited 1×
“In addition, a significant improvement in blood pressure and endothelial function among hypertensive patients was observed [77,78].”
BackgroundSobhani, M., Farzaei, M. H., Kiani, S., & Khodarahmi, R. (2021) · Food Reviews International · doi:10.1080/87559129.2020.1717523 · Cited by 155 · cited 1×
“Furthermore, PPPs are known to attenuate inflammatory pathways thanks to their capacity to inactivate NF-κB [98].”
BackgroundDietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
Valenti, L. V. C., Riso, P., Mazzocchi, A., Porrini, M., Fargion, S. R., & Agostoni, C. V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/145421 · Cited by 151 · cited 3×
“Both the down-regulation of SREBP-1c and the upregulation of PPARα seem to be modulated by AMPK activation (by phosphorylation) at the hepatic level.”
BackgroundSelf-citationShafiei, F., Salari-Moghaddam, A., Larijani, B., & Esmaillzadeh, A. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuy070 · Cited by 147
Nutritional therapy for nonalcoholic fatty liver disease
Dongiovanni, P., Lanti, C., Riso, P., & Valenti, L. V. C. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.024 · Cited by 144
Self-citationAbenavoli, L., Greco, M., Milic, N., Accattato, F., Foti, D., Gulletta, E., & Luzza, F. (2017) · Nutrients · doi:10.3390/nu9080870 · Cited by 144 · cited 7×
“[47] Total: 50 Italy NAFLD patients of 18–65 years of age and BMI over 25 kg/m2 6 months Energy restriction MD; antioxidant supplementation”
BackgroundResultInfluentialThe Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
Iqbal, U., Perumpail, B. J., Akhtar, D., Kim, D., & Ahmed, A. (2019) · Medicines · doi:10.3390/medicines6010041 · Cited by 136
Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
Zarghamravanbakhsh, P., Frenkel, M., & Poretsky, L. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100149 · Cited by 131
Godos, J., Marventano, S., Mistretta, A., Galvano, F., & Grosso, G. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2017.1285870 · Cited by 128 · cited 2×
“PPs are secondary metabolic products of plants, and for this reason are widely distributed in fruits, vegetables, whole grains, and olive oil [88].”
BackgroundKawaguchi, T., Charlton, M., Kawaguchi, A., Yamamura, S., Nakano, D., Tsutsumi, T., Zafer, M., & Torimura, T. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1723751 · Cited by 122 · cited 1×
“[49] in their meta-analysis, where an MD intervention significantly reduced liver stiffness.”
BackgroundIs there an optimal diet for weight management and metabolic health?
Thom, G., & Lean, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.056 · Cited by 119
Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study
Montemayor, S., Mascaró, C. M., Ugarriza, L., Casares, M., Llompart, I., Abete, I., Zulet, M. Á., Martínez, J. A., Tur, J. A., & Bouzas, C. (2022) · Nutrients · doi:10.3390/nu14153186 · Cited by 119
Vedala, A., Wang, W., Neese, R. A., Christiansen, M. P., & Hellerstein, M. K. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600200-jlr200 · Cited by 117
Mediterranean Diet Effect: an Italian picture
Azzini, E., Polito, A., Fumagalli, A., Intorre, F., Venneria, E., Durazzo, A., Zaccaria, M., Ciarapica, D., Foddai, M. S., Mauro, B., et al. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-125 · Cited by 113
Valls, R.-M., Farràs, M., Suárez, M., Fernández-Castillejo, S., Fitó, M., Konstantinidou, V., Fuentes, F., López-Miranda, J., Giralt, M., Covas, M.-I., et al. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2014.06.107 · Cited by 106 · cited 1×
“In addition, a significant improvement in blood pressure and endothelial function among hypertensive patients was observed [77,78].”
BackgroundBakaloudi, D. R., Chrysoula, L., Kotzakioulafi, E., Theodoridis, X., & Chourdakis, M. (2021) · Nutrients · doi:10.3390/nu13051514 · Cited by 92 · cited 1×
“A systematic review and meta-analysis on adherence to MD showed a significant reduction in WC [63].”
BackgroundCarotenoids and fatty liver disease: Current knowledge and research gaps
Clugston, R. D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158597 · Cited by 88 · cited 1×
“MD is also characterized by the high content of numerous bioactive compounds such as carotenoids [85,86], but of PPs above all others [87,88].”
BackgroundAssociation Between Dietary Fiber Intake and Non-alcoholic Fatty Liver Disease in Adults
Zhao, H., Yang, A., Mao, L., Quan, Y., Cui, J., & Sun, Y. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.593735 · Cited by 85 · cited 3×
“[82], who showed a statistically significant negative association between the intakes of total cereal, fruit, and vegetable fiber with NAFLD among over 6000 participants over 20 years of age.”
BackgroundJiménez‐Sánchez, A., Martínez-Ortega, A. J., Remón-Ruiz, P., Piñar-Gutiérrez, A., Cunill, J. L. P., & García‐Luna, P. P. (2022) · Nutrients · doi:10.3390/nu14071440 · Cited by 83 · cited 1×
“Numerous studies have reported the beneficial effects of olive oil in reducing cardiovascular risk, improving lipid metabolism (preventing the oxidation of LDL-C, thereby reducing LDL atherogenesis), and glycemic levels [74,75].”
BackgroundMarin-Alejandre, B. A., Abete, I., Cantero, I., Monreal, J. I., Elorz, M., Herrero, J. I., Benito-Boillos, A., Quiroga, J., Martinez-Echeverria, A., Uriz-Otano, J. I., et al. (2019) · Nutrients · doi:10.3390/nu11102543 · Cited by 82 · cited 3×
“Seven measured the intrahepatic fat content (IHF) [39–44,46]; six measured hepatic stiffness and steatosis [39,40,42,43,45,47]; and thr e m asured the fatty liver index (FLI) as a score to indicate severity [43,45,47].”
BackgroundRistic-Medic, D., Kovacic, M., Takic, M., Arsic, A., Petrovic, S., Paunovic, M., Jovicic, M., & Vucic, V. (2020) · Nutrients · doi:10.3390/nu13010015 · Cited by 81
Clifford, T., Acton, J. P., Cocksedge, S. P., Davies, K. A. B., & Bailey, S. J. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06041-x · Cited by 81 · cited 1×
“PPs are recognized as being a strong inducer of nuclear factor-erythroid 2-related factor 2 (Nrf2), and consequently are involved in the production of numerous antioxidant enzymes that are able to counteract oxidative stress [97].”
BackgroundNon-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids
Akhlaghi, M. (2016) · Phytotherapy Research · doi:10.1002/ptr.5667 · Cited by 78 · cited 1×
“Several independent mechanisms have been identified and can, at least in part, explain the prevention of the progression of liver damage [36,90,91].”
BackgroundNeuenschwander, M., HOFFMANN, G. E., Schwingshackl, L., & Schlesinger, S. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00534-1 · Cited by 77 · cited 1×
“[59], in their systematic review and network meta-analysis of studies performed in subjects with type 2 diabetes mellitus, reported a positive effect on HDL-C and TG levels, but not TC, compared to the control diet.”
BackgroundGeorge, E. S., Reddy, A., Nicoll, A. J., Ryan, M. C., Itsiopoulos, C., Abbott, G., Johnson, N. A., Sood, S., Roberts, S. K., & Tierney, A. C. (2022) · Liver International · doi:10.1111/liv.15264 · Cited by 76 · cited 1×
“[41] Total: 42 Australia NAFLD patients of over 18 years of age and BMI of 32 ± 6 kg/m2 3 months Low-fat diet, MD”
Golabi, P., Paik, J. M., Eberly, K. E., de Avila, L., Alqahtani, S. A., & Younossi, Z. M. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100556 · Cited by 76
Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?
Spooner, M. H., & Jump, D. Β. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000539 · Cited by 72 · cited 1×
“PUFAs, omega-3 fatty acids in particular, have been reported to improve insulin sensitivity and to reduce inflammation and oxidative stress [30,31].”
BackgroundFranco, I., Bianco, A., Mirizzi, A., Campanella, A., Bonfiglio, C., Sorino, P., Notarnicola, M., Tutino, V., Cozzolongo, R., Giannuzzi, V., et al. (2020) · Nutrients · doi:10.3390/nu13010066 · Cited by 68 · cited 2×
“[48] also reported a reduction in HOMA-IR in all intervention arms.”
BackgroundMediterranean Diet, Food Consumption and Risk of Late-Life Depression: The Mugello Study
Pagliai, G., Sofi, F., Vannetti, F., Caiani, S., Pasquini, G., Molino Lova, R., Cecchi, F., Sorbi, S., & Macchi, C. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1019-3 · Cited by 66
Cao, X., Xia, J., Zhou, Y., Wang, Y., Xia, H., Wang, S., Liao, W., & Sun, G. (2022) · Foods · doi:10.3390/foods11131982 · Cited by 65 · cited 1×
“MUFAs have been shown to improve waist circumference, high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), and glucose levels [28,29].”
BackgroundMontemayor, S., Bouzas, C., Mascaró, C. M., Casares, M., Llompart, I., Abete, I., Angullo-Martinez, E., Zulet, M. Á., Martínez, J. A., & Tur, J. A. (2022) · Nutrients · doi:10.3390/nu14112223 · Cited by 62 · cited 5×
“Seven measured the intrahepatic fat content (IHF) [39–44,46]; six measured hepatic stiffness and steatosis [39,40,42,43,45,47]; and three measured the fatty liver index (FLI) as a score to indicate severity [43,45,47].”
BackgroundMethodInfluentialDietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity
Zhu, Y., Hu, Y., Zhang, Y., Rao, S., Mo, Y., Zhang, H., Liang, S., Zhang, Z., & Yang, W. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1038435 · Cited by 60 · cited 2×
“Specifically, omega-3 may improve and induce an independent anti-inflammatory effect via the suppression of tumor necrosis factor (TNF) and interleukin6 (IL-6), which are mainly involved in the inflammation process [82,83], while omega-6 may have a pro-inflammatory role due to their direct relationship with the produc…”
BackgroundMoosavian, S. P., Arab, A., & Paknahad, Z. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.10.008 · Cited by 55 · cited 3×
“Other meta-analyses reported a beneficial effect of MD in the control of BW, WC, and other anthropometric parameters in subjects with NAFLD [55,61].”
BackgroundResultSanz‐París, A., Matía-Martín, P., Martín-Palmero, Á., Gómez‐Candela, C., & Robles, M. C. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.02.036 · Cited by 55
Di Renzo, L., Cioccoloni, G., Falco, S., Abenavoli, L., Moia, A., Sinibaldi Salimei, P., & De Lorenzo, A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1680-7 · Cited by 54 · cited 1×
“They found similar results in terms of weight reduction when compared to low-fat and low-carbohydrate diets [65].”
ResultMäkelä, T. N., Tuomainen, T., Hantunen, S., & Virtanen, J. K. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac150 · Cited by 54 · cited 1×
“In addition, PUFAs promote a shift in metabolism from FA synthesis and storage toward FA oxidation, with a favorable effect on hepatic steatosis [79].”
BackgroundAsbaghi, O., Choghakhori, R., Ashtary‐Larky, D., & Abbasnezhad, A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.03.003 · Cited by 52 · cited 1×
“Asbaghi and colleagues [60] reported that a MD significantly decreased the serum levels of TG and TC (other than HOMA-IR) in comparison to a control diet in NAFLD patients.”
ResultGuo, H., Li, D., Ling, W., Feng, X., & Xia, M. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m013375 · Cited by 52
Extra Virgin Olive Oil Polyphenols Promote Cholesterol Efflux and Improve HDL Functionality
Berrougui, H., Ikhlef, S., & Khalil, A. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/208062 · Cited by 51 · cited 1×
“Numerous studies have reported the beneficial effects of olive oil in reducing cardiovascular risk, improving lipid metabolism (preventing the oxidation of LDL-C, thereby reducing LDL atherogenesis), and glycemic levels [74,75].”
BackgroundBaratta, F., Pastori, D., Bartimoccia, S., Cammisotto, V., Cocomello, N., Colantoni, A., Nocella, C., Carnevale, R., Ferro, D., Angelico, F., et al. (2020) · Nutrients · doi:10.3390/nu12061732 · Cited by 51 · cited 3×
“The use of the MD affects liver enzymes by improving proteins associated with liver functions in general, and the most interesting finding was that the MD significantly reduced AST, but had no significant effect on ALT [52].”
BackgroundMethodInfluentialDietary management of dyslipidemia and the impact of dietary patterns on lipid disorders
Agarwala, A., Petersen, K. S., Jafari, F. M., & Kris‐Etherton, P. M. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.11.003 · Cited by 50 · cited 1×
“Another RCT found MD to be a good dietary approach to reducing body fat mass [66].”
BackgroundDel Bo', C., Marino, M., Martini, D., Tucci, M., Ciappellano, S., Riso, P., & Porrini, M. (2019) · Nutrients · doi:10.3390/nu11020391 · Cited by 47 · cited 1×
“MD has been positively associated with numerous positive effects [13,14].”
BackgroundSelf-citationSangouni, A. A., Zadeh, S. H., Mozaffari–Khosravi, H., & Hosseinzadeh, M. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521002270 · Cited by 46
Bayram, H. M., Majoo, F. M., & Öztürkcan, A. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.06.026 · Cited by 45 · cited 1×
“Several independent mechanisms have been identified and can, at least in part, explain the prevention of the progression of liver damage [36,90,91].”
BackgroundMusazadeh, V., Karimi, A., Malekahmadi, M., Ahrabi, S. S., & Dehghan, P. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13750 · Cited by 44 · cited 2×
“Furthermore, PUFAs may act by controlling the inflammation process occurring in non-alcoholic steatohepatitis (NASH) [80,81], with an opposite effect found for omega 3 and omega 6.”
BackgroundDietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!
Katsiki, N., Stoian, A. P., & Rizzo, M. (2022) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.10.001 · Cited by 42
Park, G. S. H., Jung, S., Wellen, K. E., & Jang, C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00614-x · Cited by 39 · cited 1×
“The benefits of dietary fiber have also highlighted the potential role the gut microbiota plays in the improvement of NAFLD, weight loss, as well as in the improvement of metabolic diseases, in that the higher consumption of dietary fiber (mainly in the form of oligofructose), decreases the gut dysbiosis by providing…”
BackgroundOut of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease
Parks, E., Yki-Järvinen, H., & Hawkins, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92407 · Cited by 35 · cited 6×
“Several studies have shown that a reduced intake of SFAs is associated with a reduction in TC, LDL-C, and TGs [67,68].”
BackgroundInfluentialUeno (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000200 · Cited by 34 · cited 1×
“For example, the epigallocatechin-3-gallate supplement has been shown to improve insulin sensitivity and promote the functional recovery of insulin receptor substrate-1 in a model of nonalcoholic steatohepatitis [95].”
BackgroundHwang, Y. P., Kim, H. G., Choi, J. H., Truong, M., Tran, T. T. P., Chun, H. K., Chung, Y. C., Jeong, T. C., & Jeong, H. G. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200529 · Cited by 33
Abbate, M., Mascaró, C. M., Montemayor, S., Barbería-Latasa, M., Casares, M., Gómez, C., Angullo-Martinez, E., Tejada, S., Abete, I., Zulet, M. A., et al. (2021) · Nutrients · doi:10.3390/nu13020629 · Cited by 28 · cited 8×
“[40] reported statistically reduced IHF; whereas IHF was reduced but was not statistically significant, as reported by George et al.”
BackgroundMethodResultInfluentialEcheverría, F., Bustamante, A., Sambra, V., Álvarez, D., Videla, L. A., & Valenzuela, R. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210825111350 · Cited by 28
Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!
Katsiki, N., Stoian, A. P., & Rizzo, M. (2022) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2022.07.002 · Cited by 22
Insulin resistance in nonalcoholic fatty liver disease
Park, J. H. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)80070-8 · Cited by 21
Quantum coherence spectroscopy to measure dietary fat retention in the liver
Lindeboom, L., de Graaf, R. A., Nabuurs, C. I. H. C., van Ewijk, P. A., Hesselink, M. K. C., Wildberger, J. E., Schrauwen, P., & Schrauwen‐Hinderling, V. B. (2016) · JCI Insight · doi:10.1172/jci.insight.84671 · Cited by 18 · cited 1×
“[72] showed the incorporation of 13C-labeled fatty acids into IHTGs after a single high-fat meal, suggesting that a substantial amount of liver fat can be derived directly from the storage of meal-derived fat, particularly given the increased insulin levels that would be expected following such a meal.”
BackgroundWojda, A., Janczy, A., & Małgorzewicz, S. (2021) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5515 · Cited by 18
Milano, A., Kabbaha, S., & Thorlund, K. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200175 · Cited by 11
Uli, G. B., Asyahir, S. R., & Harti, L. B. (2023) · Amerta Nutrition · doi:10.20473/amnt.v7i1.2023.139-146 · Cited by 3 · cited 1×
“[57], in their systematic review, showed that MD could lower LDL, TGs, TC, and fasting blood glucose levels, while increasing HDL-C in overweight and obese individuals.”
Background
Cited by
Eslam, M., Fan, J.-G., Yu, M.-L., Wong, V. W.-S., Cua, I. H., Liu, C.-J., Tanwandee, T., Gani, R., Seto, W.-K., Alam, S., et al. (2025) · Hepatology International · doi:10.1007/s12072-024-10774-3 · Cited by 170
Fan, J., Xu, X., Yang, R.-X., Nan, Y., Wei, L., Jia, J., Zhuang, H., Shi, J., Li, X., Cm, S., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00311 · Cited by 152
Panganiban, J. A., Kehar, M., Ibrahim, S. H., Hartmann, P., Sood, S., Hassan, S. M., Ramirez, C. M., Kohli, R., Censani, M., Mauney, E. E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100164 · Cited by 73
“There are several adult RCT that show improved intrahepatic fat, liver stiffness, liver enzymes, both on TE and US [83 – 87].”
Hamamah, S., Iatcu, O. C., & Covașă, M. (2024) · Nutrients · doi:10.3390/nu17010143 · Cited by 57
Arita, V. A., Cabezas, M. C., Hernández Vargas, J. A., Trujillo-Cáceres, S. J., Mendez Pernicone, N., Bridge, L. A., Raeisi-Dehkordi, H., Dietvorst, C. A. W., Dekker, R., Uriza-Pinzón, J. P., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04320-7 · Cited by 43
Metadata
- Authors
- Del Bo’, C., Perna, S., Allehdan, S., Rafique, A., Saad, S., AlGhareeb, F., Rondanelli, M., Tayyem, R. F., Marino, M., Martini, D., & Riso, P.
- Affiliations
- Department of Food, Environmental and Nutritional Sciences (DeFENS), Division of Human Nutrition, Università degli Studi di Milano, 20133 Milano, Italy
- University of Milan (IT)
- University of Bahrain (BH)
- University of Pavia (IT)
- Qatar University (QA)
- Corresponding author
- Perna, Simone
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-05-09
- Volume
- 15
- Issue
- 10
- Pages
- 2250
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10222807
- OpenAlex
- W4378515068
- Cited by
- 80
- References
- 101
- Citations by year
- 2026: 18 · 2025: 40 · 2024: 20 · 2023: 2
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Qatar University QSpace (Qatar University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- Mediterranean diet, non-alcoholic fatty liver disease, lipid profile, abdominal obesity, liver enzymes, liver fibrosis, intrahepatic fat, gamma-glutamyl transferase, alanine aminotransferase, total cholesterol, waist circumference, caloric restriction, low-fat diet, monounsaturated fatty acids, polyunsaturated fatty acids, physical activity
- MeSH terms
- Adult, Alanine Transaminase, Humans, Lipids, Liver Cirrhosis, Obesity, Diet, Mediterranean, Obesity, Abdominal, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.